ArticleRadiology case reports2011
Positive somatostatin receptor scintigraphy in accessory spleen mimicking recurrent neuroendocrine tumor.
Article in Radiology case reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 4 citations in OpenAlex.
- False Positive Findings ofMolecular imaging and radionuclide therapy · 2025Article
- Impact of PET data driven respiratory motion correction and BSREM reconstruction ofScientific reports · 2021Article
- Spleen Scan forNuclear medicine and molecular imaging · 2020Article
- [Embryonal malformation suggests malignant tumor in the tail of the pancreas].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the case of a female patient who had a neuroendocrine tumor in the pancreatic tail. Followup using (68)Ga DOTA-d-Phe(1)-Tyr(3)-octreotide (DOTATOC) positron-emission tomography (PET)/computed tomography (CT) detected a round, well-circumscribed nodular mass that exhibited positive somatostatin receptors. This finding was highly suggestive of an accessory spleen; however, due to the slight elevation of the tumor marker, recurrence of the tumor or lymph node metastasis of the endocrine tumor was considered as well. Ultimately, splenic scintigraphy (SS) confirmed an accessory spleen. This case shows the benefit of splenic scintigraphy in excluding a recurrent neuroendocrine tumor by confirming an accessory spleen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.